Vinay Chandrasekhara

Dr. Vinay Chandrasekhara


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2018 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
SESherif Elhanafi
Sherif Elhanafi
NMNadim Mahmud
Nadim Mahmud
NVNorge Vergara
Norge Vergara
MKMichael L Kochman
Michael L Kochman
KDKoushik K Das
Koushik K Das
VCVinay Chandrasekhara
Vinay Chandrasekhara

1 October 2021 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
VCVinay Chandrasekhara
Vinay Chandrasekhara
SESherif Elhanafi
Sherif Elhanafi
ASAndrew C. Storm
Andrew C. Storm
NTNaoki Takahashi
Naoki Takahashi
NLNam Ju Lee
Nam Ju Lee
BDBarham K. Abu Dayyeh
Barham K. Abu Dayyeh

20 December 2019 in Hepatology
Verified
Journal Article
Closed access
PDF file
TMThomas Malikowski
Thomas Malikowski
MLMichael J. Levy
Michael J. Levy
FGFerga C. Gleeson
Ferga C. Gleeson
ASAndrew C. Storm
Andrew C. Storm
EVEric J. Vargas
Eric J. Vargas
VCVinay Chandrasekhara
Vinay Chandrasekhara

30 September 2019 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
KKKaran Kaura
Karan Kaura
TSTarek Sawas
Tarek Sawas
FBFateh Bazerbachi
Fateh Bazerbachi
ASAndrew C. Storm
Andrew C. Storm
JMJohn A. Martin
John A. Martin
VCVinay Chandrasekhara
Vinay Chandrasekhara

24 April 2022 in Cancers
Verified
Journal Article
Open access
PDF file
KMKatsuyuki Miyabe
Katsuyuki Miyabe
VCVinay Chandrasekhara
Vinay Chandrasekhara
NWNicha Wongjarupong
Nicha Wongjarupong
JCJun Chen
Jun Chen
LYLu Yang
Lu Yang
LRLewis R Roberts
Lewis R Roberts
Background: Primary sclerosing cholangitis (PSC) is a major risk factor for cholangiocarcinoma (CCA). We investigated biliary and fecal microbiota to determine whether specific microbes in the bile or stool are associated with PSC or CCA. Methods: Bile was obtained from 32 patients with PSC, 23 with CCA with PSC, 26 with CCA without PSC, and 17 controls. Over 90% of bile samples were from patients with perihilar CCA. Stool was obtained from 31 patients with PSC (11 were matched to bile), 16 with CCA with PSC (10 matched to bile), and 11 with CCA without PSC (6 matched to bile). Microbiota composition was assessed using 16SrRNA-marker-based sequencing and was compared between groups. Results: Bile has a unique microbiota distinguished from negative DNA controls and stool. Increased species richness and abundance of Fusobacteria correlated with duration of PSC and characterized the biliary microbiota in CCA. Stool microbiota composition showed no significant differences between groups. Conclusions: We identified a unique microbial signature in the bile of patients with increased duration of PSC or with CCA, suggesting a role for microbiota-driven inflammation in the pathogenesis and or progression to perihilar CCA. Further studies are needed to test this hypothesis.

17 May 2023 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
RGRabih Ghazi
Rabih Ghazi
JAJad P. AbiMansour
Jad P. AbiMansour
TMTala Mahmoud
Tala Mahmoud
JMJohn A. Martin
John A. Martin
RLRyan J. Law
Ryan J. Law
VCVinay Chandrasekhara
Vinay Chandrasekhara